Results 141 to 150 of about 720,196 (232)

Cardiac amyloidosis in a Swiss autopsy cohort – distribution and clinical relevance

Swiss Medical Weekly
AIMS: Cardiac amyloidosis (CA) characterised by myocardial amyloid accumulation is likely underdiagnosed. The distribution and extent of myocardial amyloid deposits remain unclear.
Albert Baschong, Sara Ersözlü, Frank Ruschitzka, Andreas J. Flammer, Christoph A. Meier, Zsuzsanna Varga, Holger Moch, Umberto Maccio   +7 more
doaj   +1 more source

Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States

ClinicoEconomics and Outcomes Research, 2019
Tiffany P Quock,1 Tingjian Yan,2 Ryan Tieu,2 Anita D’Souza,3 Michael S Broder21Medical Affairs, Prothena Biosciences Inc, South San Francisco, CA, USA; 2Health Services Research, Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA;
Quock TP, Yan T, Tieu R, D'Souza A, Broder MS   +4 more
doaj  

Cardiac Amyloidosis: A Narrative Review of Diagnostic Advances and Emerging Therapies

Biomedicines
Background/Objectives: Cardiac amyloidosis (CA) is an underdiagnosed and potentially life-threatening infiltrative cardiomyopathy characterized by the extracellular deposition of misfolded amyloid fibrils in cardiac tissue. It is most commonly associated
Dana Emilia Movila, Alexandru Catalin Motofelea, Dragos Cozma, Oana Albai, Alexandra Christa Sima, Minodora Andor, Tudor Ciocarlie, Simona Ruxanda Dragan   +7 more
doaj   +1 more source

Cardiac amyloidosis - Experience in a tertiary cardiac referral centre

, 2008
Amyloidosis is an uncommon systemic disease characterized by deposition of insoluble fibrillar protein in different organs and the prognosis is poor if the heart is involved.
Chow, WH, Kwong, YL, Chau, EMC, Wang, E
core   +1 more source

True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis

Haematologica, 2018
Avinainder Singh, Hallie I. Geller, Kevin M. Alexander, Robert F. Padera, Richard N. Mitchell, Sharmila Dorbala, Jorge J. Castillo, Rodney H. Falk   +7 more
doaj   +1 more source

Myocardial Perfusion in Cardiac Amyloidosis

European Journal of Heart Failure
Abstract Aims Cardiac involvement is the main driver of clinical outcomes in systemic amyloidosis and preliminary studies support the hypothesis that myocardial ischaemia contributes to cellular damage.
Chacko, Liza, Kotecha, Tushar, Ioannou, Adam, Patel, Niket, Martinez‐Naharro, Ana, Razvi, Yousuf, Patel, Rishi, Massa, Paolo, Venneri, Lucia, Brown, James, Porcari, Aldostefano, Knott, Kristopher, Manisty, Charlotte, Knight, Daniel, Lockie, Tim, Rakhit, Roby, Lachmann, Helen, Wechelakar, Ashutosh, Whelan, Carol, Ponticos, Markella, Moon, James, González, Arantxa, Gilbertson, Janet, Riefolo, Mattia, Leone, Ornella, Xue, Hui, Hawkins, Philip, Kellman, Peter, Gillmore, Julian, Fontana, Marianna   +29 more
openaire   +4 more sources

A propensity-matched analysis of cardiac operation in patients with and without cardiac amyloidosisCentral MessagePerspective

JTCVS Open
Objective: There are limited data on the outcome of routine cardiac operations in patients with cardiac amyloidosis. This study studied the impact of amyloidosis on early and late results of cardiac operations.
Akshay Chauhan, MBBS, Kevin L. Greason, MD, Daniel D. Borgeson, MD, Austin Todd, MS, John M. Stulak, MD, Richard C. Daly, MD, Juan A. Crestanello, MD, Hartzell V. Schaff, MD   +7 more
doaj   +1 more source

Cardiac Amyloidosis in a Horse [PDF]

Journal of Veterinary Internal Medicine, 2003
Yvette S, Nout, Kenneth W, Hinchcliff, John D, Bonagura, Kathryn M, Meurs, Tracey L, Papenfuss   +4 more
openaire   +2 more sources

Antemortem Underdiagnosis of Cardiac Amyloidosis in Sudden Cardiac Death Victims

Background Cardiac amyloidosis is an increasingly recognized condition in clinical practice. Its role in sudden cardiac death (SCD), particularly as a first manifestation, remains poorly characterized. Objectives The goal of this study was to assess
Sheppard, MN, Papadakis, M, Behr, ER, Westaby, J, Finocchiaro, G, Ciliberti, G, Sharma, S   +6 more
core   +1 more source

Temporal evolution of transthyretin cardiac amyloidosis phenotypes on cardiac magnetic resonance

reservedBackground: Advances in cardiac imaging and disease awareness have led to earlier and more frequent diagnosis of Transthyretin Cardiac Amyloidosis (ATTR-CA).
MONTERSINO, MARTA
core